Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A W Partin

Showing results (161-170 of 234) with videos related to

Pageof 24
Sort By:
The Journal of Urology|September 1, 1996
Serum prostate specific antigen levels after transurethral resection of prostate: a longitudinal characterization in men with benign prostatic hyperplasiaL S Marks, F J Dorey, T Rhodes, et al.
Cancer|July 1, 1992
Use of nuclear morphometry, gleason histologic scoring, clinical stage, and age to predict disease-free survival among patients with prostate cancerA W Partin, G D Steinberg, R V Pitcock, et al.
Urology|March 15, 2001
Artificial neural network model for the assessment of lymph node spread in patients with clinically localized prostate cancerJ T Batuello, E J Gamito, E D Crawford, et al.
Cancer Research|February 15, 1993
Nuclear matrix protein patterns in human benign prostatic hyperplasia and prostate cancerA W Partin, R H Getzenberg, M J CarMichael, et al.
Cancer|April 8, 1999
Comparison of clinical staging algorithms and 111indium-capromab pendetide immunoscintigraphy in the prediction of lymph node involvement in high risk prostate carcinoma patientsT J Polascik, M J Manyak, M K Haseman, et al.
Journal of the National Cancer Institute|November 6, 2003
Quantitative GSTP1 methylation and the detection of prostate adenocarcinoma in sextant biopsiesSusan V Harden, Harriette Sanderson, Steven N Goodman, et al.
Urology|January 11, 2000
A neural network predicts progression for men with gleason score 3+4 versus 4+3 tumors after radical prostatectomyM Han, P B Snow, J I Epstein, et al.
Urology|May 1, 1995
Relationship between changes in prostate-specific antigen and the percent of prostatic epithelium in men with benign prostatic hyperplasiaJ A Cadeddu, J D Pearson, B R Lee, et al.
The Journal of Urology|July 1, 1993
The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancerA W Partin, J Yoo, H B Carter, et al.
The Prostate|May 20, 1999
Bioimpedance: novel use of a minimally invasive technique for cancer localization in the intact prostateB R Lee, W W Roberts, D G Smith, et al.
Pageof 24

Showing results (161-170 of 234) with videos related to

Sort By:
Pageof 24
The Journal of Urology|September 1, 1996
Serum prostate specific antigen levels after transurethral resection of prostate: a longitudinal characterization in men with benign prostatic hyperplasiaL S Marks, F J Dorey, T Rhodes, et al.
Cancer|July 1, 1992
Use of nuclear morphometry, gleason histologic scoring, clinical stage, and age to predict disease-free survival among patients with prostate cancerA W Partin, G D Steinberg, R V Pitcock, et al.
Urology|March 15, 2001
Artificial neural network model for the assessment of lymph node spread in patients with clinically localized prostate cancerJ T Batuello, E J Gamito, E D Crawford, et al.
Cancer Research|February 15, 1993
Nuclear matrix protein patterns in human benign prostatic hyperplasia and prostate cancerA W Partin, R H Getzenberg, M J CarMichael, et al.
Cancer|April 8, 1999
Comparison of clinical staging algorithms and 111indium-capromab pendetide immunoscintigraphy in the prediction of lymph node involvement in high risk prostate carcinoma patientsT J Polascik, M J Manyak, M K Haseman, et al.
Journal of the National Cancer Institute|November 6, 2003
Quantitative GSTP1 methylation and the detection of prostate adenocarcinoma in sextant biopsiesSusan V Harden, Harriette Sanderson, Steven N Goodman, et al.
Urology|January 11, 2000
A neural network predicts progression for men with gleason score 3+4 versus 4+3 tumors after radical prostatectomyM Han, P B Snow, J I Epstein, et al.
Urology|May 1, 1995
Relationship between changes in prostate-specific antigen and the percent of prostatic epithelium in men with benign prostatic hyperplasiaJ A Cadeddu, J D Pearson, B R Lee, et al.
The Journal of Urology|July 1, 1993
The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancerA W Partin, J Yoo, H B Carter, et al.
The Prostate|May 20, 1999
Bioimpedance: novel use of a minimally invasive technique for cancer localization in the intact prostateB R Lee, W W Roberts, D G Smith, et al.
Pageof 24